EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lactobacillus plantarum NCHBL-004 modulates high-fat diet–induced weight gain and enhances GLP-1 production for blood glucose regulation

Ah-Ra Jang, Do-Hyeon Jung, Tae-Sung Lee, Jeon-Kyung Kim, Yu-Bin Lee, Jae-Young Lee, So-Yeon Kim, Yung-Choon Yoo, Jae-Hee Ahn, Eun-Hye Hong, Chae-Won Kim, Su Min Kim und 4 weitere

Nutrition · 2024

DOI: 10.1016/j.nut.2024.112565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, 2024. Verfasst von Ah-Ra Jang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Animal Medicine, College of Veterinary Medicine and Animal Medical Institute, Chonnam National University, Gwangju 61186, Republic of Kore…. Hauptthemen laut MEDLINE: Blood Glucose, Diet, High-Fat, Glucagon-Like Peptide 1, Lactiplantibacillus plantarum. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, INNOPOLIS Foundation, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study investigated the therapeutic potential of Lactobacillus plantarum NCHBL-004 (NCHBL-004) in the treatment of obesity and associated metabolic disorders. METHODS: Mice were fed either a normal diet (ND) or a high-fat diet (HFD) with oral administration of NCHBL-004. After euthanasia, blood, liver and adipose tissue were collected. Furthermore, the microbiome and short-chain fatty acids (SCFAs) were analyzed from feces. RESULTS: Oral administration of live NCHBL-004 to mice fed a HFD resulted in notable reductions in weight gain, improvements in glucose metabolism, and maintenance of balanced lipid levels. A comparative analysis with other Lactobacillus strains highlighted the superior efficacy of NCHBL-004. Moreover, heat-killed NCHBL-004 demonstrated beneficial effects similar to those of live NCHBL-004. Additionally, administration of live NCHBL-004 induced glucagon-like peptide 1 (GLP-1) production and increased the levels of short-chain fatty acids (SCFAs), including acetate and propionate, in feces, positively influencing liver lipid metabolism and mitigating inflammation. Consistent with this, analysis of the gut microbiome following NCHBL-004 administration showed increases in SCFA-producing microbes with increased proportions of Lactobacillus spp. and a significant increase in the proportion of microbes capable of promoting GLP-1 secretion. CONCLUSIONS: These findings underscore the potential of both live and inactivated NCHBL-004 as potential therapeutic approaches to managing obesity and metabolic disorders, suggesting avenues for further investigation and clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseDiet, High-FatGlucagon-Like Peptide 1Lactiplantibacillus plantarumObesityProbioticsWeight GainAnimalsMaleMiceFatty Acids, VolatileFecesGastrointestinal MicrobiomeLipid MetabolismLiverMice, Inbred C57BL

Stichwörter der Autor:innen

GLP-1Lactobacillus plantarum NCHBL-004Liver lipid metabolismObesityShort-chain fatty acids

Substanzen

Blood GlucoseFatty Acids, VolatileGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Laboratory Animal Medicine, College of Veterinary Medicine and Animal Medical Institute, Chonnam National University, Gwangju 61186, Republic of Korea; Nodcure, INC., 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of K…
  • Laboratory Animal Medicine, College of Veterinary Medicine and Animal Medical Institute, Chonnam National University, Gwangju 61186, Republic of Korea.
  • School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju 54896, Republic of Korea.
  • Nodcure, INC., 77 Yongbong-ro, Buk-gu, Gwangju 61186, Republic of Korea.
  • Department of Microbiology, College of Medicine, Konyang University, Daejeon, Republic of Korea.
  • Department of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea; KNU Researcher training program for Innovative Drug Development Research Team for Intractable Diseases (BK21 plus), Kangwon Nation…

Förderung

  • National Research Foundation of Korea
  • INNOPOLIS Foundation
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Jang, A. R., Jung, D. H., Lee, T. S., Kim, J. K., Lee, Y. B., Lee, J. Y., Kim, S. Y., Yoo, Y. C., Ahn, J. H., Hong, E. H., Kim, C. W., Kim, S. M., Yoo, H. H., Huh, J. Y., Ko, H. J., & Park, J. H. (2024). Lactobacillus plantarum NCHBL-004 modulates high-fat diet–induced weight gain and enhances GLP-1 production for blood glucose regulation. Nutrition. https://doi.org/10.1016/j.nut.2024.112565

Vancouver

Jang AR, Jung DH, Lee TS, Kim JK, Lee YB, Lee JY, et al. Lactobacillus plantarum NCHBL-004 modulates high-fat diet–induced weight gain and enhances GLP-1 production for blood glucose regulation. Nutrition. 2024. doi:10.1016/j.nut.2024.112565

BibTeX
@article{Jang2024,
  author = {Jang, Ah-Ra and Jung, Do-Hyeon and Lee, Tae-Sung and Kim, Jeon-Kyung and Lee, Yu-Bin and Lee, Jae-Young and Kim, So-Yeon and Yoo, Yung-Choon and Ahn, Jae-Hee and Hong, Eun-Hye and Kim, Chae-Won and Kim, Su Min and Yoo, Hye Hyun and Huh, Joo Young and Ko, Hyun-Jeong and Park, Jong-Hwan},
  title = {Lactobacillus plantarum NCHBL-004 modulates high-fat diet–induced weight gain and enhances GLP-1 production for blood glucose regulation},
  journal = {Nutrition},
  year = {2024},
  doi = {10.1016/j.nut.2024.112565}
}
Kostenlos starten →